Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis
Over 99% of GP’s reject GMS contract changes, with medics assembling to take industrial action
Following the announcement of the 2024/25 national GP General Medical Services (GMS) contract by the Department of Health and Social Care and NHS England, over 99% of GPs have voted against it.
Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples
Nuclera eProtein Discovery system installed at leading academic institutes
11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of Cambridge, University of SoutELRIG UK announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024
Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October
Bio-Rad launches three StarBright Red Dyes and expands range of antibody markers conjugated to StarBright Violet Dyes to enhance immunology research
Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research.
eg technology publish case study on redesigning Endomag's Sentimag® surgical guidance system
Find out how eg technology worked with Endomag to develop the Sentimag® surgical guidance system designed to transform breast cancer care.
Professor Kai-Michael Toellner joins the Immunology programme as a senior group leader
Prof Kai-Michael Toellner is welcomed to the Institute as he joins the Institute as a senior group leader in the Immunology research programme. Prof. Toellner’s expertise in immune cell differentiation, antibody production and how long-term immune memory is formed is highly complementary to the work of the programme. He was previously Professor of Adaptive Immunology at the Institute of…
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr. Frank F. Craig, current CEO and co-founder, announces his retirement after leading the Company for 14 years.
PlaqueTec closes $8 million equity financing
The financing was led by Lord Moynihan of Chelsea alongside The Future Fund, with support from existing investors Funding will support ongoing BIOPATTERN trial and build BIOCARTA database to transform the treatment of CADCambridge, UK, 30
Communigage wins UK Enterprise Award
Here at Communigage, a messaging and employer brand strategy consulting firm for small and medium-sized enterprises (SMEs), we are thrilled to announce that we have been chosen as the winner of the 2024 SME News UK Enterprise Award for Best New SME Consulting Firm.
Global pharma companies’ return on R&D investment increases after record low
Projected return on innovation in pharma R&D in 2023 has risen to 4.1 per cent, indicating a potential recovery from the long term downward trend in R&D productivity; The top 20 global pharmaceutical companies spent $145 billion on R&D investments in 2022-23*; AI is yet to become a ‘game-changer’ in pharma R&D.
Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes.Guardtech Group off to a stormer in 2024 as action-packed quarter one flies by
Haverhill-based cleanroom design & build experts are working on more than 20 significant projects concurrently – an all-time high
Registration open for our Scientific Conference in June
We are excited to announce that you can now secure your spot for the 2nd NIHR BioResource Scientific Conference, taking place online on Wednesday 19 June 2024 from 9.30am to 12.30pm.
Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease
$5 million equity investment and initial $1.5 million grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to improve outcomes in the developing world Funding represents the first time the foundation has taken anSharing a free white paper to compare your IT support service
Breathe Technology wanted to share some valuable insights with you regarding the changing landscape of IT support for businesses and schools like yours.
CN Bio raises $21 million USD in first close of Series B investment round
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutionsCambridge,
Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance
First senior executive appointment made following Company launch to oversee strategic development of clinical programs
Improving adherence in Asthma treatment
Asthma, a common respiratory disorder affects more than 8 million people in the UK alone [1]. Despite the availability of effective treatments, inhaled corticosteroids (ICS) which are the mainstay of asthma treatment, often show limited efficacy because of suboptimal patient adherence.
Sable&Hawkes deliver new website for Granta Veterinary Specialists
As part of a wider brand identity for our client Granta Veterinary Specialists – Sable&Hawkes, working with Pick Digital, have delivered a new corporate website.
Neurolentech signs technology access partnership with Kaerus Bioscience to advance neurodevelopmental disorder research
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.
Guardtech Group strengthen sales team with addition of new GMP Commercial Manager
Cleanroom construction experts set to elevate full-package offering with recruitment of experienced Pharma specialist John Edwards
Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth.
Navigating payer challenges in rare disease
Clinical and economic evidence generation across rare diseases is challenging due to intrinsic disease characteristics, misalignment on treatment costs, and inadequate traditional evaluation frameworks.